Source:http://linkedlifedata.com/resource/pubmed/id/14629625
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2003-11-21
|
pubmed:abstractText |
Primary sclerosing cholangitis (PSC) is a chronic cholestatic disorder with a presumed autoimmune aetiopathogenesis. We have recently described a novel organ-specific rat model of fibrosing cholangitis induced by intrabiliary administration of the hapten-reagent 2,4,6-trinitrobenzenesulfonic acid (TNBS) with similarities to human PSC. In the present report, we have evaluated the long-term outcome of TNBS-induced cholangitis in this model. Mild stenosis of the common bile duct of female Lewis rats (n = 18) was achieved by subtotal ligation and cholangitis induced by TNBS injection (50 mg/kg) into the dilated bile duct after a second laparotomy. After 8 and 12 months, we found no evidence of cholangitis in serum chemistry or histology or retrograde cholangiography of TNBS-treated rats. Antineutrophil cytoplasmic antibodies were positive in 75% of animals but were not predictive of liver damage. Tumour necrosis factor-alpha levels were not elevated in serum or in mononuclear spleen cell supernatants. Our findings suggest that a single initial insult is not sufficient to trigger chronic progressive inflammation. Rather, perpetuation of inflammation probably requires additional stimuli.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antineutrophil...,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Trinitrobenzenesulfonic Acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0300-9475
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
533-40
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14629625-Alanine Transaminase,
pubmed-meshheading:14629625-Animals,
pubmed-meshheading:14629625-Antibodies, Antineutrophil Cytoplasmic,
pubmed-meshheading:14629625-C-Reactive Protein,
pubmed-meshheading:14629625-Cholangitis, Sclerosing,
pubmed-meshheading:14629625-Chronic Disease,
pubmed-meshheading:14629625-Disease Models, Animal,
pubmed-meshheading:14629625-Disease Progression,
pubmed-meshheading:14629625-Female,
pubmed-meshheading:14629625-Humans,
pubmed-meshheading:14629625-Liver,
pubmed-meshheading:14629625-Rats,
pubmed-meshheading:14629625-Rats, Inbred Lew,
pubmed-meshheading:14629625-Trinitrobenzenesulfonic Acid
|
pubmed:year |
2003
|
pubmed:articleTitle |
Long-term evaluation of a rat model of chronic cholangitis resembling human primary sclerosing cholangitis.
|
pubmed:affiliation |
I. Medical Clinic, University of Mainz, Mainz, Germany. mgoetz@mail.uni-mainz.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|